阿奇霉素对小儿呼吸道肺炎支原体感染治疗有效性的研究  

Study on the Efficacy of Azithromycin in the Treatment of Mycoplasma Pneumoniae Infection in Children with Respiratory Tract Infection

作　　者：张弟 范宝生 ZHANG Di;FAN Baosheng(Department of Pediatric,Jining Yanzhou District People's Hospital,Jining 272100,Shandong,China)

机构地区：[1]济宁市兖州区人民医院儿科,山东济宁272100

出　　处：《系统医学》2024年第20期115-117,共3页Systems Medicine

摘　　要：目的分析阿奇霉素治疗小儿呼吸道肺炎支原体感染的效果。方法非随机选取济宁市兖州区人民医院2022年12月—2023年11月收治的肺炎支原体感染患儿100例,按治疗方法分为两组,每组50例。对照组采用常规抗生素治疗,研究组采用阿奇霉素治疗。比较两组患儿血清炎症因子水平、治疗有效率。结果治疗后,研究组炎症因子水平低于对照组,差异有统计学意义(P均<0.05)。研究组总有效率为94.00%(47/50),高于对照组的70.00%(35/50),差异有统计学意义(χ^(2)=9.756,P<0.05)。结论小儿呼吸道肺炎支原体感染治疗中采用阿奇霉素能够有效提高治疗有效率。Objective To analyze the efficacy of azithromycin in the treatment of mycoplasma pneumoniae infections of the pediatric respiratory tract.Methods A total of 100 cases of children with mycoplasma pneumoniae infection ad⁃mitted to Yanzhou District People's Hospital in Jining City from December 2022 to November 2023 were nonrandomly selected.They were divided into two groups according to treatment methods,with 50 cases in each group.The control group was treated with conventional antibiotics,and the study group was treated with azithromycin.Com⁃pared the serum inflammatory factor levels and treatment efficiency of children in the two groups.Results After treat⁃ment,the levels of inflammatory factors in the study group were lower than those in the control group,and the differ⁃ences were statistically significant(all P<0.05).The total effective rate of the study group was 94.00%(47/50),which was higher than 70.00%(35/50)in the control group,and the difference was statistically significant(χ^(2)=9.756,P<0.05).Conclusion The use of azithromycin in the treatment of pediatric respiratory mycoplasma pneumoniae infection can effectively improve the treatment efficiency.

关 键 词：阿奇霉素 小儿呼吸道肺炎 支原体感染 

分 类 号：R725.6[医药卫生—儿科]